Literature DB >> 22205657

Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.

R Brad Jones1, Vivek M John, Diana V Hunter, Eric Martin, Shariq Mujib, Vesna Mihajlovic, Peter C Burgers, Theo M Luider, Gabor Gyenes, Neil C Sheppard, Devi Sengupta, Ravi Tandon, Feng-Yun Yue, Erika Benko, Colin Kovacs, Douglas F Nixon, Mario A Ostrowski.   

Abstract

T-cell responses to human endogenous retrovirus (HERV) K(HML-2) Gag and Env were mapped in HIV-1-infected subjects using 15 mer peptides. Small peptide pools and high concentrations were used to maximize sensitivity. In the 23 subjects studied, only three bona fide HERV-K(HML-2)-specific responses were detected. At these high peptide concentrations, we detected false-positive responses, three of which were mapped to an HIV-1 Gag peptide contaminant. Thus, HERV-K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected by 15 mer peptide mapping.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205657      PMCID: PMC3272926          DOI: 10.1128/CVI.05583-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

1.  An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.

Authors:  J Yang; H P Bogerd; S Peng; H Wiegand; R Truant; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Peptide libraries for T cell epitope screening and characterization.

Authors:  Stuart J Rodda
Journal:  J Immunol Methods       Date:  2002-09-01       Impact factor: 2.303

3.  Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes.

Authors:  Tara Beattie; Rupert Kaul; Tim Rostron; Tao Dong; Philippa Easterbrook; Walter Jaoko; Joshua Kimani; Francis Plummer; Andrew McMichael; Sarah Rowland-Jones
Journal:  AIDS       Date:  2004-07-23       Impact factor: 4.177

4.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7.

Authors:  K Reus; J Mayer; M Sauter; D Scherer; N Müller-Lantzsch; E Meese
Journal:  Genomics       Date:  2001-03-15       Impact factor: 5.736

6.  Insertional polymorphisms of full-length endogenous retroviruses in humans.

Authors:  G Turner; M Barbulescu; M Su; M I Jensen-Seaman; K K Kidd; J Lenz
Journal:  Curr Biol       Date:  2001-10-02       Impact factor: 10.834

7.  Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.

Authors:  Rika Draenert; Marcus Altfeld; Christian Brander; Nesli Basgoz; Colleen Corcoran; Alysse G Wurcel; David R Stone; Spyros A Kalams; Alicja Trocha; Marylyn M Addo; Philip J R Goulder; Bruce D Walker
Journal:  J Immunol Methods       Date:  2003-04-01       Impact factor: 2.303

8.  Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database.

Authors:  M Tristem
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Analysis of antigen-specific T-cell responses with synthetic peptides--what kind of peptide for which purpose?

Authors:  Felix Kiecker; Mathias Streitz; Bernhard Ay; Georgy Cherepnev; Hans-Dieter Volk; Rudolf Volkmer-Engert; Florian Kern
Journal:  Hum Immunol       Date:  2004-05       Impact factor: 2.850

10.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  7 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.

Authors:  R Brad Jones; Keith E Garrison; Shariq Mujib; Vesna Mihajlovic; Nasra Aidarus; Diana V Hunter; Eric Martin; Vivek M John; Wei Zhan; Nabil F Faruk; Gabor Gyenes; Neil C Sheppard; Ingrid M Priumboom-Brees; David A Goodwin; Lianchun Chen; Melanie Rieger; Sophie Muscat-King; Peter T Loudon; Cole Stanley; Sara J Holditch; Jessica C Wong; Kiera Clayton; Erick Duan; Haihan Song; Yang Xu; Devi SenGupta; Ravi Tandon; Jonah B Sacha; Mark A Brockman; Erika Benko; Colin Kovacs; Douglas F Nixon; Mario A Ostrowski
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

3.  Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Authors:  Marta J Gonzalez-Hernandez; James D Cavalcoli; Maureen A Sartor; Rafael Contreras-Galindo; Fan Meng; Manhong Dai; Derek Dube; Anjan K Saha; Scott D Gitlin; Gilbert S Omenn; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

4.  Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.

Authors:  Benjamin Kraus; Katrin Fischer; Sarah M Büchner; Winfried S Wels; Roswitha Löwer; Katja Sliva; Barbara S Schnierle
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

5.  Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.

Authors:  Michelle Vincendeau; Ingmar Göttesdorfer; Julia M H Schreml; Armand G Ngounou Wetie; Jens Mayer; Alex D Greenwood; Markus Helfer; Susanne Kramer; Wolfgang Seifarth; Kamyar Hadian; Ruth Brack-Werner; Christine Leib-Mösch
Journal:  Retrovirology       Date:  2015-03-24       Impact factor: 4.602

6.  Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression.

Authors:  Matthew L Bendall; Miguel de Mulder; Luis Pedro Iñiguez; Aarón Lecanda-Sánchez; Marcos Pérez-Losada; Mario A Ostrowski; R Brad Jones; Lubbertus C F Mulder; Gustavo Reyes-Terán; Keith A Crandall; Christopher E Ormsby; Douglas F Nixon
Journal:  PLoS Comput Biol       Date:  2019-09-30       Impact factor: 4.475

7.  Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.

Authors:  R Brad Jones; Fabio E Leal; Aaron M Hasenkrug; Aluisio C Segurado; Douglas F Nixon; Mario A Ostrowski; Esper G Kallas
Journal:  J Negat Results Biomed       Date:  2013-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.